Row triangle Shape Decorative svg added to bottom

About Us

Independent 340B Compliance Advisory Services

Row triangle Shape Decorative svg added to top

Virtue 340B is an Independent 340B Compliance Advisory Firm

We provide independent audits, continuous monitoring, education, and governance evaluation services to hospitals, health systems, rural hospitals, and Federally Qualified Health Centers (FQHCs) across the United States.

Our role is singular: to help executive leadership understand where 340B exposure may exist, translate regulatory complexity into defensible oversight decisions, and ensure programs remain structurally sound over time.

We do not administer the 340B program, operate pharmacies, dispense medications, or provide legal representation. We operate as an independent evaluation layer — assessing how a covered entity's 340B program functions in practice, where risk may be accumulating, and what corrective actions strengthen defensibility.

businesspeople-working-laptop-office

The Problem Virtue 340B Was Built to Solve

The 340B Drug Pricing Program creates meaningful financial value for eligible covered entities — but it also introduces material regulatory, operational, and governance risk.

Program requirements govern

  • patient eligibility
  • contract pharmacy oversight
  • duplicate discount prevention
  • documentation standards.
  • HRSA audits covered entities to verify adherence.
  • Manufacturer audits have increased.

The regulatory environment continues to evolve.

 

Most covered entities manage their 340B programs through a combination of internal teams, third-party administrators (TPAs), and contract pharmacy partners. Each plays an operational role. None is structurally positioned to provide independent evaluation of the program as a whole, because each has execution responsibilities, financial relationships, or system limitations that limit objective oversight.

That is the gap Virtue 340B was built to fill.

An independent advisory firm sits outside operational execution.

It has no stake in transaction volume, no vendor relationships to protect, and no software platform to defend. Its only function is to evaluate, report, and recommend — clearly, accurately, and without commercial incentive — so leadership can make informed, defensible oversight decisions before exposure becomes public or financial.

Book a Consultation

The Covered Entities Virtue 340B Serves

Virtue 340B works with covered entities that participate in the 340B Drug Pricing Program and require independent compliance oversight. Our primary client base includes:

  • Rural Hospitals

    Navigating program compliance requirements with lean internal teams and limited dedicated compliance infrastructure

Within those organizations, the stakeholders we work most directly with include 340B Program Directors, Pharmacy Directors, Compliance Officers, Internal Audit Departments, and Chief Financial Officers — the individuals who carry direct responsibility for the program's compliance posture, financial exposure, and governance defensibility. Our work is designed to give these stakeholders clarity that they can document, explain, and stand behind.

Book a Consultation

Specialized 340B Consulting for Complex Operations

The 340B ecosystem includes several distinct categories of organization, each serving a different function. Understanding those distinctions matters when a covered entity is evaluating what kind of outside support it needs. Clarity on these distinctions protects covered entities from role confusion and ensures that oversight functions are not conflated with operational execution.

Virtue 340B is an Independent 340B Compliance Advisory Firm.

That classification has a specific meaning.

In a well-structured 340B program, all of these roles have a place. They are complementary, not interchangeable.

Virtue 340B’s role is the independent evaluation layer — the objective third-party review that operational vendors, administrators, and dispensing partners are not structurally positioned to provide.

That separation is intentional and foundational to credible oversight.

Apexus is the prime vendor for the 340B program and administers the 340B Advanced Certification (340B ACE) credentialing program. Apexus provides program-wide resources, pricing tools, and education. It is not a compliance advisory firm and does not conduct independent audits of covered entity operations. There is no affiliation between Virtue 340B and Apexus.

patient-care

Independent Advisory Services for the 340B Program

Virtue 340B provides six core service areas, all within the scope of independent 340B compliance advisory services:

Independent 340B Audits — Point-in-time compliance assessments evaluating diversion controls, duplicate discount monitoring, provider eligibility validation, contract pharmacy oversight, and governance documentation — designed to surface material exposure before it results in adverse audit findings.

340B Continuous Monitoring — Ongoing quarterly review of program controls, transaction activity, and oversight documentation to reduce the likelihood of operational drift between formal audit periods.

340B Education Programs — Structured education sessions covering 340B program requirements, operational processes, documentation standards, and compliance responsibilities for pharmacy, clinical, and compliance teams.

Third-Party Administrator Configuration Standardization — Assessment of TPA configuration logic, eligibility parameters, and system alignment with documented program policies, ensuring that system logic aligns with documented patient definitions and regulatory requirements.

Manufacturer Restrictions Management — Evaluation of manufacturer-imposed contract pharmacy policies and their operational implications within 340B program administration.

Contract Pharmacy Opportunity Analysis — Analysis of dispensing data, geographic distribution, and program participation metrics to inform contract pharmacy network planning decisions.

Contact Us for Ongoing Support

How Virtue 340B Was Founded

Virtue 340B was founded in November 2022 by Edward Vargas, CIA. Edward Vargas, CIA founded Virtue 340B after more than a decade working across hospital-level 340B program management, internal audit, health system compliance, and third-party administrator environments — roles that provided firsthand visibility into where compliance oversight frequently breaks down.

Many covered entities were operating reactively — correcting findings after audits rather than identifying exposure early. Independent, structured oversight was often absent or under-resourced.

Virtue 340B was built to fill that role. The firm's structure, service design, and hiring reflect that purpose: a team of credentialed advisors with real operational backgrounds, organized to provide the kind of objective, specific, and actionable compliance guidance that covered entities need to protect their programs.

Meet The Team
Row triangle Shape Decorative svg added to top

Credentials That Back Every Engagement

Certified Internal Auditor (CIA) — The CIA designation, awarded by the Institute of Internal Auditors (IIA), is the global standard for internal audit professionals. It signifies demonstrated competency in audit methodology, risk assessment, and compliance evaluation. The credential reflects formal training in risk-based audit methodology and internal control evaluation — disciplines directly applicable to independent 340B compliance assessments. Edward Vargas, CIA holds this credential.

Apexus Advanced 340B Certified Expert (340B ACE) — The 340B ACE credential is awarded by Apexus and signifies advanced knowledge of 340B program requirements, policies, and operational management. Edward Vargas, CIA and Katy Lees, MSBA, 340B ACE hold this credential.

Published expertise — Edward Vargas is the author of 340B Mastery: Transforming Risk into Reward in 340B Pharmacy Program Management, a published resource on 340B compliance, risk assessment, governance, and program management.

100+ independent 340B audits conducted across all major covered entity types, including health systems, large hospitals, rural hospitals, and FQHCs, providing broad visibility into recurring risk patterns across covered entity types and program structures.

National recognition — Featured speaker at national and regional 340B industry and healthcare compliance events.

Eddie-founder-headshot

Ready to Transform Your 340B Program Management?

To determine whether independent 340B compliance oversight would add clarity and defensibility to your organization’s program, schedule a consultation.

Schedule a 340B Consultation

Recent Articles That Explain Our Approach

Why Independent Oversight Matters in Vendor-Managed 340B Programs

Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility

Virtue 340B partners with HANYS Marketplace

Why 340B Matters: A Response to PhRMA’s Middleman Narrative

Planning for Change: The Intersection of IRA Maximum Fair Price and the 340B Rebate Policies

340B Rebate Pilot: Why Purchase Data Isn’t the Right Tool for Duplicate Discount Prevention

Stay on Top of 340B News!

Join the 340B professionals who rely on Virtue 340B Insights for:

 

⚠️ Timely regulatory updates explained with practical guidance so you know exactly how changes affect your program.

📋 Action-ready audit tools like checklists, templates, and monitoring tips designed to strengthen your compliance oversight.

💰 Proven cost-saving insights that help covered entities maximize 340B savings while staying aligned with HRSA expectations.

🎯 Lessons from real-world audits that highlight common pitfalls and provide strategies to avoid costly compliance errors.

 

Subscribe now and stay ahead of the curve – because in 340B compliance, being reactive costs more than being proactive.

Company Facts: Virtue 340B

  • Legal Name: Virtue 340B, LLC
  • Entity Type: Limited Liability Company (LLC)
  • Founded: 2022-11-22
  • Headquarters: Ontario, New York, United States
Read all Business Facts about Virtue 340B